| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $39,791,931 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA259480 | MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia | 000 | 5 | NIH | 12/8/2025 | $310,541 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01AG086063 | A Pilot Trial of High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Older Adults with HIV. | 000 | 3 | NIH | 2/11/2026 | $125,982 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R37CA296615 | Quality of End-of-Life Care for Children with Cancer: A COG Observational Study | 000 | 2 | NIH | 2/12/2026 | $555,731 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS117698 | Understanding the Etiology of CASK Associated Epileptic Encephalopathy | 000 | 6 | NIH | 12/12/2025 | $334,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK115752 | Injury Response Mediated Pathogenesis in Renal Ciliopathies | 000 | 8 | NIH | 12/15/2025 | $530,077 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK141552 | CDKN1A (p21) regulation of cyst growth | 000 | 2 | NIH | 12/15/2025 | $635,232 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI162698 | Functional Implications of Tfh Cell Heterogeneity after Infection | 000 | 5 | NIH | 2/5/2026 | $554,964 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI189667 | FCRL Regulation in B Cell Tolerance and Malignancy | 000 | 1 | NIH | 2/18/2026 | $496,628 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DA059368 | Mechanisms of operant reward seeking in prefrontal somatostatin-expressing interneurons | 000 | 2 | NIH | 3/5/2026 | $710,278 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30DA057821 | Role of Reelin protein in the cellular and behavioral response to drugs of abuse | 000 | 3 | NIH | 3/5/2026 | $53,249 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K23MD017288 | Longitudinal study of cognitive remediation to prepare for transition of care in youth with sickle cell disease | 000 | 5 | NIH | 2/25/2026 | $114,624 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01ES034846 | The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration | 000 | 3 | NIH | 12/19/2025 | $414,266 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG081228 | Drugs repositioning to target TREM2 in Alzheimer disease | 000 | 4 | NIH | 3/4/2026 | $564,154 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R00DA055641 | Information encoding by spatiotemporal patterns of dopamine release | 000 | 4 | NIH | 3/4/2026 | $248,999 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31ES034986 | Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies | 000 | 3 | NIH | 12/19/2025 | $52,692 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UH3NS130202 | Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD | 001 | 3 | NIH | 3/5/2026 | $153,148 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U24NS107223 | StrokeBelt StrokeNet | 001 | 8 | NIH | 3/5/2026 | $37,614 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MH129351 | Determining the role of social reward learning in social anhedonia in first-episode psychosis using motivational interviewing as a probe in a perturbation-based neuroimaging approach | 000 | 4 | NIH | 12/4/2025 | $738,793 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01EY032753 | ACE2 on gut barrier dysfunction and BRB disruption | 000 | 5 | NIH | 12/4/2025 | $369,431 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T9952104 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $1,175,000 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG085793 | Targeting Ceramide Signaling: Enhancing Healthy Aging and Combating Tauopathy in Mammals | 000 | 2 | NIH | 12/3/2025 | $663,173 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HL031197 | Mitochondrial DNA Injury is a Key Contributor to the Development of Chemical Lung Injury | 000 | 31 | NIH | 3/2/2026 | $304,492 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HL031197 | Mitochondrial DNA Injury is a Key Contributor to the Development of Chemical Lung Injury | 000 | 31 | NIH | 3/2/2026 | $305,471 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG082352 | Peripheral Biomarkers for Early Diagnosis of Mixed Pathologies in AD/ADRD | 000 | 4 | NIH | 2/26/2026 | $720,169 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA276683 | Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer | 000 | 4 | NIH | 2/26/2026 | $610,112 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG077395 | Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease | 001 | 4 | NIH | 2/23/2026 | $44,144 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HL167872 | Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation | 000 | 4 | NIH | 2/24/2026 | $440,193 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 001 | 5 | NIH | 2/23/2026 | $717,674 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG085793 | Targeting Ceramide Signaling: Enhancing Healthy Aging and Combating Tauopathy in Mammals | 001 | 2 | NIH | 2/24/2026 | $73,686 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01ES034846 | The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration | 001 | 3 | NIH | 1/13/2026 | $122,700 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG061800 | Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease | 001 | 7 | NIH | 2/24/2026 | $76,714 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21NS147535 | AMPA Receptor Function at Interneuron Synapses | 000 | 1 | NIH | 1/15/2026 | $186,250 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA258248 | Credentialing next-generation human glioma models for precision therapeutics | 000 | 5 | NIH | 12/22/2025 | $505,680 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134310 | Differentiating slow from rapidly progressive ADPKD by cell-specific mitochondrial and transcriptional profiles | 000 | 3 | NIH | 1/9/2026 | $489,684 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG092916 | Cocoa to maximize exercise training in older adults - COMET Trial | 000 | 1 | NIH | 12/26/2025 | $409,750 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR073004 | Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin | 000 | 7 | NIH | 12/24/2025 | $565,073 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA269365 | ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation | 000 | 4 | NIH | 1/14/2026 | $305,724 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI164717 | Mechanisms Controlling the Development and Function of Intestinal Effector Treg cells | 000 | 4 | NIH | 1/16/2026 | $729,679 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35GM156375 | Mechanisms of Molecular Motors in Transcription and Protein Homeostasis | 000 | 2 | NIH | 1/8/2026 | $334,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI182085 | AhR suppression of T-bet+ B cells in SLE | 000 | 2 | NIH | 12/1/2025 | $572,963 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI191107 | Mechanisms of STAT1 and STAT3 canonical and persistent activation in physiology and disease | 000 | 2 | NIH | 2/11/2026 | $646,763 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI172796 | Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection | 000 | 4 | NIH | 12/29/2025 | $641,350 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR072697 | Nanoscale structure and function of desmosomes | 000 | 7 | NIH | 12/16/2025 | $362,180 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K08HL157651 | Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease | 000 | 5 | NIH | 3/6/2026 | $161,624 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR081646 | Mechanism of Wnt5a signaling in skeletal development and diseases | 001 | 4 | NIH | 3/6/2026 | $533,408 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS117698 | Understanding the Etiology of CASK Associated Epileptic Encephalopathy | 001 | 6 | NIH | 3/5/2026 | $37,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AI173778 | Tegument Envelope Protein Interactions in CMV Envelopment | 000 | 4 | NIH | 1/7/2026 | $481,131 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UG3NS141843 | Low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | 000 | 1 | NIH | 3/6/2026 | $556,686 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21MH141410 | Determining the role of localized dopamine signals in learning | 000 | 1 | NIH | 3/6/2026 | $409,750 |
|
